Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 5;11(7):2022.
doi: 10.3390/jcm11072022.

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support

Cecilia Berardi  1 , Claudio A Bravo  2 , Song Li  2 , Maziar Khorsandi  3 , Jeffrey E Keenan  3 , Jonathan Auld  2 , Sunny Rockom  2 , Jennifer A Beckman  2 , Claudius Mahr  2
Affiliations
Review

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support

Cecilia Berardi et al. J Clin Med. .

Abstract

The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management of these patients. In this review, we discuss the history of LVADs, evaluating survival and complications over time. We also aim to discuss practical aspects of the medical and surgical management of LVAD patients and future directions for outcome improvement in this population.

Keywords: LVAD; heart failure; mechanical support.

PubMed Disclaimer

Conflict of interest statement

Mahr is an investigator/consultant for Abbott and Abiomed.

Figures

Figure 1
Figure 1
Left ventricular assist device configuration.
See this image and copyright information in PMC

References

    1. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
    1. Goldstein D.J., Oz M.C., Rose E.A. Implantable left ventricular assist devices. N. Engl. J. Med. 1998;339:1522–1533. doi: 10.1056/NEJM199811193392107. - DOI - PubMed
    1. Rose E.A., Gelijns A.C., Moskowitz A., Heitjan D.F., Stevenson L.W., Dembitsky W.P., Long J.W., Ascheim D.D., Tierney A.R., Levitan R.G., et al. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure. N. Engl. J. Med. 2001;345:1435–1443. doi: 10.1056/NEJMoa012175. - DOI - PubMed
    1. Long J.W., Kfoury A.G., Slaughter M.S., Silver M., Milano C., Rogers J., Delgado R., Frazier O. Long-Term Destination Therapy With the HeartMate XVE Left Ventricular Assist Device: Improved Outcomes Since the REMATCH Study. Congest. Hearth Fail. 2005;11:133–138. doi: 10.1111/j.1527-5299.2005.04540.x. - DOI - PubMed
    1. Park S.J., Tector A., Piccioni W., Raines E., Gelijns A., Moskowitz A., Rose E., Holman W., Furukawa S., Frazier O.H., et al. Left ventricular assist devices as destination therapy: A new look at survival. J. Thorac. Cardiovasc. Surg. 2005;129:9–17. doi: 10.1016/j.jtcvs.2004.04.044. - DOI - PubMed

LinkOut - more resources